Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

89%

8 of 9 completed trials have results

Key Signals

1 recruiting8 with results

Enrollment Performance

Analytics

N/A

5(55.6%)

Phase 1

2(22.2%)

Phase 2

2(22.2%)

9Total

N/A(5)

Phase 1(2)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06767566Phase 1Recruiting

Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery

Role: lead

NCT05906368Not ApplicableCompleted

Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypotension

Role: lead

NCT05907213Phase 1Completed

Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1)

Role: lead

NCT05487196Phase 2Completed

Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia

Role: lead

NCT05280743Completed

Precision Opioid Care After Cesarean Delivery (PRECISE-CD)

Role: lead

NCT04925765Not ApplicableCompleted

Virtual Reality Biofeedback for Postpartum Anxiety and Depression

Role: lead

NCT04365465Not ApplicableCompleted

BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control

Role: lead

NCT04037085Phase 2Completed

Ketamine to Improve Recovery After Cesarean Delivery - Part 1

Role: lead

NCT03022526Not ApplicableCompleted

CSE v. Epidural for Postpartum Depression

Role: lead

NCT03830307Not ApplicableCompleted

NSS-Bridge Device for Post-Cesarean Delivery Pain

Role: lead

All 10 trials loaded